Stockreport

Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced [Read more]